Aetna Medical Policy Updates – September 2022

Click here to view the Aetna Medical Policy Updates »

September 2022 Aetna Medical Policy Updates:

• Abatacept (Orencia)
• Abatacept (Orencia) [Medicare]
• Abdominal Aortic Aneurysm Screening
• Acoustic Heart Sound Recording and Computer Analysis
• Adalimumab (Humira)
• Adoptive Immunotherapy and Cellular Therapy
• Alopecia Areata
• Alzheimer’s Disease: Experimental Tests
• Anakinra (Kineret)
• Anecortave Acetate (Retaane)
• Ankle Orthoses, Ankle-Foot Orthoses (AFOs), and Knee-Ankle-Foot Orthoses (KAFOs)
• Antiprothrombin Antibody Testing
• Auditory Processing Disorder (APD)
• Autism Spectrum Disorders
• Autotransfusers
• Axicabtagene Ciloleucel (Yescarta)
• Azacitidine (Vidaza)
• Back Pain – Invasive Procedures
• Benign Prostatic Hyperplasia
• Benign Skin Lesion Removal
• Benralizumab (Fasenra)
• Biofeedback
• Body Surface Potential Mapping
• Bone and Tendon Graft Substitutes and Adjuncts
• Brain Natriuretic Peptide Testing
• Brexanolone (Zulresso)
• Broth Culture Testing for Interstitial Cystitis
• Bunionectomy
• Calcitonin Injection
• Cardiac Rehabilitation: Outpatient
• Cataract Surgery
• Cerebral Perfusion Studies
• Certolizumab Pegol (Cimzia)
• Color-Flow Doppler Echocardiography in Adults
• Comparative Genomic Hybridization (CGH)
• Constraint-Induced Therapy
• Denosumab (Prolia and Xgeva)
• Denosumab (Prolia and Xgeva) [Medicare]
• Diphtheria, Tetanus, and Pertussis Vaccines
• Donor Lymphocyte Infusion
• Drug-Eluting Stents
• Dry Hydrotherapy (Hydromassage, Aquamassage, Water Massage)
• Dysphagia Therapy
• Electrical Stimulation for Nausea, Vomiting and Motion Sickness (PrimaBella and ReliefBand) and Other Selected Indications
• Electrical Stimulation for Pain
• Electromagnetic Navigation-Guided Bronchoscopy
• Endovascular Repair of Aortic Aneurysms
• Erythropoiesis Stimulating Agents [Medicare]
• Esophageal and Airway pH Monitoring
• Etanercept
• Evaluation of Sinusitis
• Extracorporeal Immunoadsorption (Prosorba Column)
• Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries
• Eye Prosthesis
• Facial Prostheses, External
• Fecal Bacteriotherapy
• Foot Orthotics
• Functional Electrical Stimulation and Neuromuscular Electrical Stimulation
• Gastrointestinal Manometry
• Gender Affirming Surgery
• Glaucoma Testing
• Golimumab (Simponi and Simponi Aria)
• Golimumab (Simponi and Simponi Aria) [Medicare]
• Growth Hormone (GH) and Growth Hormone Antagonists
• Hammertoe Repair
• Hematopoietic Cell Transplantation for Aplastic Anemia and other Bone Marrow Failure Syndromes
• Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia
• Hematopoietic Cell Transplantation for Ovarian Cancer
• Hematopoietic Cell Transplantation for Selected Leukemias
• Hematopoietic Cell Transplantation for Testicular Cancer
• Hematopoietic Cell Transplantation for Thalassemia Major and Sickle Cell Anemia
• Hematopoietic Colony-Stimulating Factors (CSFs)
• Hematopoietic Colony-Stimulating Factors (CSFs) [Medicare]
• Hereditary Angioedema
• Histamine Desensitization Therapy for Intractable Headaches
• Indirect Measurement of Left Ventricular Filling Pressure (LVFP): The VeriCor System
• Infliximab
• Infliximab [Medicare]
• Interferons
• Intra-oral Appliances for Headaches and Trigeminal Neuralgia
• Ipilimumab (Yervoy)
• Joint Resurfacing
• Levator Syndrome Treatments
• Magnetic Resonance Angiography (MRA) and Magnetic Resonance Venography (MRV)
• Magnetic Resonance Cholangiopancreatography
• Magnetic Resonance Imaging (MRI) of the Breast
• Mecasermin (Increlex)
• Mepolizumab (Nucala)
• Metatarsal Phalangeal Joint Replacement
• Microwave Thermotherapy
• Multiple Sclerosis
• Multiple Sclerosis [Medicare]
• Nesiritide (Natrecor)
• Neuralgia Inducing Cavitational Osteonecrosis (NICO) and Ultrasonograph Bone Densitometer to Detect NICO
• Nivolumab (Opdivo)
• Non-myeloablative Hematopoietic Cell Transplantation (Mini-Allograft / Reduced Intensity Conditioning Transplant)
• Obstructive Sleep Apnea in Adults
• Ocular Photoscreening
• Ofatumumab (Arzerra)
• Omalizumab (Xolair)
• Orthopedic Casts, Braces and Splints
• Osteochondral Autografts (Mosaicplasty, OATS)
• Paclitaxel, Albumin-Bound (Abraxane) [Medicare]
• Parkinson’s Disease
• Phototherapy for Acne
• Polatuzumab vedotin-piiq (Polivy)
• Polymerase Chain Reaction Testing: Selected Indications
• Positron Emission Tomography (PET)
• Progestins
• Prosthetic Limb Vacuum Systems
• Psoriasis and Psoriatic Arthritis: Targeted Immune Modulators
• Psoriasis and Psoriatic Arthritis: Targeted Immune Modulators [Medicare]
• Reslizumab (Cinqair)
• Rhinometry and Rhinomanometry
• Rilonacept (Arcalyst)
• Rituximab [Medicare]
• Romosozumab-aqqg (Evenity)
• Romosozumab-aqqg (Evenity) [Medicare]
• Safety Items
• Scalp Cooling (Hypothermia) to Prevent Hair Loss During Chemotherapy
• Secukinumab (Cosentyx)
• Septoplasty and Rhinoplasty
• Signal-Averaged Electrocardiography (SAECG)
• Skin and Soft Tissue Substitutes
• Somatostatin Analogs
• Spinal Cord Stimulation
• Spinal Surgery: Laminectomy and Fusion
• Spinal Ultrasound
• Stem Cells for Hematopoietic Cell Transplant
• Subtalar Implant for Foot Deformity
• Teriparatide
• Therapeutic Phlebotomy
• Thermal Perfusion Probe for Monitoring Regional Cerebral Blood Flow
• Tisagenlecleucel (Kymriah)
• Tocilizumab (Actemra)
• Tocilizumab (Actemra) [Medicare]
• Total Ankle Arthroplasty
• Trastuzumab (Herceptin and biosimilars), Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta)
• Trastuzumab (Herceptin and biosimilars), Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) [Medicare]
• Tubal Sterilization
• Tumor Markers
• Ultrasound for Pregnancy
• Ustekinumab (Stelara)
• Ustekinumab (Stelara) [Medicare]
• Varicose Veins
• Vascular Endothelial Growth Factor Inhibitors for Ocular Indications
• Vascular Endothelial Growth Factor Inhibitors for Ocular Indications [Medicare]
• Vedolizumab (Entyvio)
• Vedolizumab (Entyvio) [Medicare]
• Ventricular Assist Devices
• Voice Therapy

Click here to view the Aetna Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.